Inogen (INGN) Cost of Revenue (2013 - 2026)

Inogen (INGN) has 14 years of Cost of Revenue data on file, last reported at $47.2 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $47.2 million, up 2.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $99.0 million (down 50.47% YoY), and the FY2025 annual result was $97.7 million, down 46.02% from the prior year.
• Cost of Revenue advanced to $47.2 million in Q1 2026 per INGN's latest filing, from -$50.2 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $131.5 million in Q4 2022 and troughed at -$50.2 million in Q4 2025.
• A 5-year average of $44.0 million and a median of $45.9 million in 2025 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2024 and 2025: Cost of Revenue surged 297.81% in 2024, then slumped 149.22% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $131.5 million in 2022, then slumped by 80.5% to $25.7 million in 2023, then surged by 297.81% to $102.0 million in 2024, then tumbled by 149.22% to -$50.2 million in 2025, then surged by 194.07% to $47.2 million in 2026.
• Business Quant data shows INGN's Cost of Revenue at $47.2 million in Q1 2026, -$50.2 million in Q4 2025, and $51.1 million in Q3 2025.